Alvogen

Alvogen is an international pharmaceuticals company focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products.

The company has commercial operations in 35 countries with 2,300 employees and operates five manufacturing and development hubs. North America is Alvogen's single largest market and other key markets include: South Korea, Romania, Bulgaria, Hungary, Taiwan, Russia and China.

Alvogen has established itself as one of the fastest growing generic pharmaceutical companies in the industry, delivering double digit revenue and profit growth annually since 2009. The Group has transformed from being a domestic US business to a global player.

Robert Wessman, CEO

Date of investment

September 2015

Fund

Fund VI

Business

Pharmaceuticals

Country

Iceland

Turnover

US$700 million

Number of employees

2,300

CEO

Robert Wessman

Company website

www.alvogen.com